Fundraising FoxYard Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Cyrus operates a protein engineering platform that combines AI and Rosetta computational design methods with a biochemistry lab performing large-scale deep mutagenesis scanning, protein stabilization, immunogenicity reduction, and affinity/specificity tuning.
AI & Machine LearningBiotechDeep TechSeattle, US
Yifan Song(CSO)inDavid Baker(Co-founder)Javier Castellanos(Executive Officer, Director)inMark(President & EVP, Business Development)
BoardLucas Nivon(CEO)in
Co-investorsAlumni VenturesAnzu PartnersArgonautic VenturesiSelect FundOrbiMedSPRINGROCK VENTURES+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.